Poor-quality antimicrobial medicines continue to proliferate across supply chains, threatening patients' health and safety, especially in low- and middle-income regions. This article discusses consequences and risks of antimicrobial resistance and other ways in which antimicrobial medicines can be of poor quality and recommends regulatory and policy reforms to help maintain supply chain resilience and quality of antimicrobial medicines.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1001/amajethics.2024.472 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!